Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Depressive Disorder and MAPK1[original query] |
|---|
| Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients. Progress in neuro-psychopharmacology & biological psychiatry 2013 Jul 44 271-8. Calati Raffaella, Crisafulli Concetta, Balestri Martina, Serretti Alessandro, Spina Edoardo, Calabrò Marco, Sidoti Antonina, Albani Diego, Massat Isabelle, Höfer Peter, Amital Daniela, Juven-Wetzler Alzbeta, Kasper Siegfried, Zohar Joseph, Souery Daniel, Montgomery Stuart, Mendlewicz Juli |
| Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology 2019 Aug 17 (3): 364-368. Calabrò Marco, Mandelli Laura, Crisafulli Concetta, Lee Soo-Jung, Jun Tae-Youn, Wang Sheng-Min, Patkar Ashwin A, Masand Prakash S, Han Changsu, Pae Chi-Un, Serretti Alessand |
| The Impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 Genetic Polymorphisms in Antidepressant Treatment Response Phenotypes. International journal of molecular sciences 2023 4 24 (7): . Santos Marlene, Lima Luis, Carvalho Serafim, Mota-Pereira Jorge, Pimentel Paulo, Maia Dulce, Correia Diana, Barroso M Fátima, Gomes Sofia, Cruz Agostinho, Medeiros R |
- Page last reviewed:Feb 1, 2024
- Content source: